Skip to main content
Erschienen in:

23.07.2018 | Original Article

Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting

verfasst von: Man Kwun Andrew Li, Anderson Chun On Tsang, Frederick Chun Pong Tsang, Wai Shing Ho, Raymand Lee, Gilberto Ka Kit Leung, Wai Man Lui

Erschienen in: Clinical Neuroradiology | Ausgabe 4/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Stenting and angioplasty of the vertebral artery (VA) is used to treat symptomatic stenosis but the long-term outcomes and complications are unclear. This study evaluated the long-term clinical outcomes and procedure-related complications in patients who underwent extracranial VA stenting and angioplasty, in particular the risks of in-stent restenosis (ISR) and stent fracture.

Methods

This was a retrospective review of consecutive patients suffering from symptomatic extracranial VA stenosis who were treated with balloon-expandable bare metal stents. The clinical and angiographical outcomes were reviewed for procedural complications, recurrent stroke, ISR and stent fracture.

Results

In this study 22 patients (17 male, 5 female) with a mean age of 63.4 years (SD 9.1 years) were included. The median follow-up was 56 months (interquartile range IQR 51.8 months). There were no periprocedural complications. The cumulative ISR risk was 45% with 6 cases detected at 1 year and 3 cases detected at 3 years post operation. The cumulative stent fracture rate at 1 year, 3 years, 5 years and the entire follow-up period were 5%, 15%, 25%, and 30%, respectively. Posterior circulation stroke occurred in 1 patient (4.5%), and 3 patients died of non-cerebrovascular causes during follow-up. Of the patients 2 with ISR and stent fracture required additional treatment.

Conclusion

The long-term ISR and stent fracture risks were high in extracranial VA stenosis treated with balloon-expandable bare metal stents. The risk of stent fracture increased over time during the follow-up period. Further studies should be conducted to clarify the long-term safety and efficacy of extracranial VA stenting.
Literatur
1.
Zurück zum Zitat Caplan LR, Wityk RJ, Pazdera L, Chang HM, Pessin MS, DeWitt LD. New England medical center posterior circulation stroke registry II. Vascular lesions. J Clin Neurol. 2005;1:31–49.CrossRef Caplan LR, Wityk RJ, Pazdera L, Chang HM, Pessin MS, DeWitt LD. New England medical center posterior circulation stroke registry II. Vascular lesions. J Clin Neurol. 2005;1:31–49.CrossRef
2.
Zurück zum Zitat Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol. 2013;12:989–98.CrossRef Markus HS, van der Worp HB, Rothwell PM. Posterior circulation ischaemic stroke and transient ischaemic attack: diagnosis, investigation, and secondary prevention. Lancet Neurol. 2013;12:989–98.CrossRef
3.
Zurück zum Zitat Gulli G, Marquardt L, Rothwell PM, Markus HS. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke. 2013;44:598–604.CrossRef Gulli G, Marquardt L, Rothwell PM, Markus HS. Stroke risk after posterior circulation stroke/transient ischemic attack and its relationship to site of vertebrobasilar stenosis: pooled data analysis from prospective studies. Stroke. 2013;44:598–604.CrossRef
4.
Zurück zum Zitat Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM. Incidence and prognosis of ≥ 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain. 2009;132:982–8.CrossRef Marquardt L, Kuker W, Chandratheva A, Geraghty O, Rothwell PM. Incidence and prognosis of ≥ 50% symptomatic vertebral or basilar artery stenosis: prospective population-based study. Brain. 2009;132:982–8.CrossRef
5.
Zurück zum Zitat Gulli G, Khan S, Markus HS. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke. 2009;40:2732–7.CrossRef Gulli G, Khan S, Markus HS. Vertebrobasilar stenosis predicts high early recurrent stroke risk in posterior circulation stroke and TIA. Stroke. 2009;40:2732–7.CrossRef
6.
Zurück zum Zitat Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke. Stroke. 2009;40:713–8.CrossRef Mazighi M, Labreuche J, Gongora-Rivera F, Duyckaerts C, Hauw JJ, Amarenco P. Autopsy prevalence of proximal extracranial atherosclerosis in patients with fatal stroke. Stroke. 2009;40:713–8.CrossRef
7.
Zurück zum Zitat Wityk RJ, Chang HM, Rosengart A, Han WC, DeWitt LD, Pessin MS, Caplan LR. Proximal extracranial vertebral artery disease in the New England medical center posterior circulation registry. Arch Neurol. 1998;55:470–8.CrossRef Wityk RJ, Chang HM, Rosengart A, Han WC, DeWitt LD, Pessin MS, Caplan LR. Proximal extracranial vertebral artery disease in the New England medical center posterior circulation registry. Arch Neurol. 1998;55:470–8.CrossRef
8.
Zurück zum Zitat Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, Uyttenboogaart M, Lo RT, Algra A, Kappelle LJ; VAST investigators. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015;14:606–14.CrossRef Compter A, van der Worp HB, Schonewille WJ, Vos JA, Boiten J, Nederkoorn PJ, Uyttenboogaart M, Lo RT, Algra A, Kappelle LJ; VAST investigators. Stenting versus medical treatment in patients with symptomatic vertebral artery stenosis: a randomised open-label phase 2 trial. Lancet Neurol. 2015;14:606–14.CrossRef
9.
Zurück zum Zitat Markus HS, Larsson SC, Kuker W, Schulz UG, Ford I, Rothwell PM, Clifton A; VIST Investigators. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89:1229–36.CrossRef Markus HS, Larsson SC, Kuker W, Schulz UG, Ford I, Rothwell PM, Clifton A; VIST Investigators. Stenting for symptomatic vertebral artery stenosis: The Vertebral Artery Ischaemia Stenting Trial. Neurology. 2017;89:1229–36.CrossRef
10.
Zurück zum Zitat Eberhardt O, Naegele T, Raygrotzki S, Weller M, Ernemann U. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg. 2006;43:1145–54.CrossRef Eberhardt O, Naegele T, Raygrotzki S, Weller M, Ernemann U. Stenting of vertebrobasilar arteries in symptomatic atherosclerotic disease and acute occlusion: case series and review of the literature. J Vasc Surg. 2006;43:1145–54.CrossRef
11.
Zurück zum Zitat Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42:2212–6.CrossRef Stayman AN, Nogueira RG, Gupta R. A systematic review of stenting and angioplasty of symptomatic extracranial vertebral artery stenosis. Stroke. 2011;42:2212–6.CrossRef
12.
Zurück zum Zitat Antoniou GA, Murray D, Georgiadis GS, Antoniou SA, Schiro A, Serracino-Inglott F, Smyth JV. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis. J Vasc Surg. 2012;55:1167–77.CrossRef Antoniou GA, Murray D, Georgiadis GS, Antoniou SA, Schiro A, Serracino-Inglott F, Smyth JV. Percutaneous transluminal angioplasty and stenting in patients with proximal vertebral artery stenosis. J Vasc Surg. 2012;55:1167–77.CrossRef
13.
Zurück zum Zitat Tsutsumi M, Kazekawa K, Onizuka M, Kodama T, Matsubara S, Aikawa H, Iko M, Nii K, Etou H, Tanaka A. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology. 2007;49:253–7.CrossRef Tsutsumi M, Kazekawa K, Onizuka M, Kodama T, Matsubara S, Aikawa H, Iko M, Nii K, Etou H, Tanaka A. Stent fracture in revascularization for symptomatic ostial vertebral artery stenosis. Neuroradiology. 2007;49:253–7.CrossRef
14.
Zurück zum Zitat Werner M, Bräunlich S, Ulrich M, Bausback Y, Schuster J, Lukhaup A, Botsios S, Scheinert D, Schmidt A. Drug-eluting stents for the treatment of vertebral artery origin stenosis. J Endovasc Ther. 2010;17:232–40.CrossRef Werner M, Bräunlich S, Ulrich M, Bausback Y, Schuster J, Lukhaup A, Botsios S, Scheinert D, Schmidt A. Drug-eluting stents for the treatment of vertebral artery origin stenosis. J Endovasc Ther. 2010;17:232–40.CrossRef
15.
Zurück zum Zitat Li Z, Zhang Y, Hong B, Deng B, Xu Y, Zhao W, Liu J, Huang Q. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents. J Clin Neurosci. 2014;21:274–7.CrossRef Li Z, Zhang Y, Hong B, Deng B, Xu Y, Zhao W, Liu J, Huang Q. Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents. J Clin Neurosci. 2014;21:274–7.CrossRef
16.
Zurück zum Zitat Sun X, Ma N, Wang B, Mo D, Gao F, Xu X, Liu L, Song L, Miao Z. The long term results of vertebral artery ostium stenting in a single center. J Neurointerv Surg. 2014;7:888–91.CrossRefPubMed Sun X, Ma N, Wang B, Mo D, Gao F, Xu X, Liu L, Song L, Miao Z. The long term results of vertebral artery ostium stenting in a single center. J Neurointerv Surg. 2014;7:888–91.CrossRefPubMed
17.
Zurück zum Zitat Langwieser N, Buyer D, Schuster T, Haller B, Laugwitz KL, Ibrahim T. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. J Endovasc Ther. 2014;21:683–92.CrossRef Langwieser N, Buyer D, Schuster T, Haller B, Laugwitz KL, Ibrahim T. Bare metal vs. drug-eluting stents for extracranial vertebral artery disease: a meta-analysis of nonrandomized comparative studies. J Endovasc Ther. 2014;21:683–92.CrossRef
18.
Zurück zum Zitat Musialek P, Langwieser N. Commentary: vertebral artery ostial stenosis stenting technique: the concept reversed? J Endovasc Ther. 2015;22:445–8.CrossRef Musialek P, Langwieser N. Commentary: vertebral artery ostial stenosis stenting technique: the concept reversed? J Endovasc Ther. 2015;22:445–8.CrossRef
19.
Zurück zum Zitat Geng X, Hussain M, Du H, Zhao L, Chen J, Su W, Ma L, Gao Z, Ding Y, Ji X. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial. J Endovasc Ther. 2015;22:436–44.CrossRef Geng X, Hussain M, Du H, Zhao L, Chen J, Su W, Ma L, Gao Z, Ding Y, Ji X. Comparison of self-expanding stents with distal embolic protection to balloon-expandable stents without a protection device in the treatment of symptomatic vertebral artery origin stenosis: a prospective randomized trial. J Endovasc Ther. 2015;22:436–44.CrossRef
20.
Zurück zum Zitat Lin YH, Kao HL. Commentary: vertebral ostium Stenting: unsolved puzzle. J Endovasc Ther. 2010;17:241–2.CrossRef Lin YH, Kao HL. Commentary: vertebral ostium Stenting: unsolved puzzle. J Endovasc Ther. 2010;17:241–2.CrossRef
21.
Zurück zum Zitat Zhou Z, Yin Q, Xu G, Yue X, Zhang R, Zhu W, Fan X, Ma M, Liu X. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium. Cardiovasc Intervent Radiol. 2011;34:481–7.CrossRef Zhou Z, Yin Q, Xu G, Yue X, Zhang R, Zhu W, Fan X, Ma M, Liu X. Influence of vessel size and tortuosity on in-stent restenosis after stent implantation in the vertebral artery ostium. Cardiovasc Intervent Radiol. 2011;34:481–7.CrossRef
22.
Zurück zum Zitat Lin YH, Hung CS, Tseng WY, Lee RK, Wang YC, Lin MS, Yeh MH, Chao CL, Ho YL, Jeng JS, Yip PK, Kao HL; National Taiwan University Carotid Artery and Vertebral Artery Stenosis (NTU CAVAS) Study Group. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc. 2008;107:253–8.CrossRef Lin YH, Hung CS, Tseng WY, Lee RK, Wang YC, Lin MS, Yeh MH, Chao CL, Ho YL, Jeng JS, Yip PK, Kao HL; National Taiwan University Carotid Artery and Vertebral Artery Stenosis (NTU CAVAS) Study Group. Safety and feasibility of drug-eluting stent implantation at vertebral artery origin: the first case series in Asians. J Formos Med Assoc. 2008;107:253–8.CrossRef
23.
Zurück zum Zitat Kakino S, Ogasawara K, Kubo Y, Kobayashi M, Kashimura H, Ogawa A. Symptomatic occlusion at the origin of the vertebral artery treated using external carotid artery—cervical vertebral artery bypass with interposed saphenous vein graft. World Neurosurg. 2008;69:164–8. Kakino S, Ogasawara K, Kubo Y, Kobayashi M, Kashimura H, Ogawa A. Symptomatic occlusion at the origin of the vertebral artery treated using external carotid artery—cervical vertebral artery bypass with interposed saphenous vein graft. World Neurosurg. 2008;69:164–8.
24.
Zurück zum Zitat Naeem AH, Al-Rumaihi G, Namavarian A, Sharma M, Boulton M. Balloon Angioplasty for in-Stent Restenosis resulting in carotid Stent fracture: literature review of Stent-in-Stent technique as a viable therapeutic option. World Neurosurg. 2017;101:818.e1–e6. Naeem AH, Al-Rumaihi G, Namavarian A, Sharma M, Boulton M. Balloon Angioplasty for in-Stent Restenosis resulting in carotid Stent fracture: literature review of Stent-in-Stent technique as a viable therapeutic option. World Neurosurg. 2017;101:818.e1–e6.
Metadaten
Titel
Long-Term Risk of In-Stent Restenosis and Stent Fracture for Extracranial Vertebral Artery Stenting
verfasst von
Man Kwun Andrew Li
Anderson Chun On Tsang
Frederick Chun Pong Tsang
Wai Shing Ho
Raymand Lee
Gilberto Ka Kit Leung
Wai Man Lui
Publikationsdatum
23.07.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
Clinical Neuroradiology / Ausgabe 4/2019
Print ISSN: 1869-1439
Elektronische ISSN: 1869-1447
DOI
https://doi.org/10.1007/s00062-018-0708-y

Neu im Fachgebiet Radiologie

Genügt die biparametrische MRT für die Prostatadiagnostik?

Die multiparametrische Magnetresonanztomografie hat einen festen Platz im Screening auf klinisch signifikante Prostatakarzinome. Ob auch ein biparametrisches Vorgehen ausreicht, ist in einer Metaanalyse untersucht worden.

Höhere Trefferquoten bei Brustkrebsscreening dank KI?

Künstliche Intelligenz unterstützt bei der Auswertung von Mammografie-Screenings und senkt somit den Arbeitsaufwand für Radiologen. Wie wirken sich diese Technologien auf die Trefferquote und die Falsch-positiv-Rate aus? Das hat jetzt eine Studie aus Schweden untersucht.

KI-gestütztes Mammografiescreening überzeugt im Praxistest

Mit dem Einsatz künstlicher Intelligenz lässt sich die Detektionsrate im Mammografiescreening offenbar deutlich steigern. Mehr unnötige Zusatzuntersuchungen sind laut der Studie aus Deutschland nicht zu befürchten.

Stumme Schlaganfälle − ein häufiger Nebenbefund im Kopf-CT?

In 4% der in der Notfallambulanz initiierten zerebralen Bildgebung sind „alte“ Schlaganfälle zu erkennen. Gar nicht so selten handelt es sich laut einer aktuellen Studie dabei um unbemerkte Insulte. Bietet sich hier womöglich die Chance auf ein effektives opportunistisches Screening?

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.